fda compounding semaglutide warning letters november 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Compounded "semaglutide" is not FDA-approved

Are you experiencing hot flashes and agonizing night sweats

One of the most surprising things people report when starting or adjusting a GLP-1 medication is feeling more hungry, not less.

Physician-led GLP-1 weight loss meds in Michigan semaglutide & tirzepatide

The supply of GLP-1 drugs tightened this week as FDA ends compounded options

GLP-1 receptor agonists, the class of drugs that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are the most important class of medications to emerge in decades.

The overall safety profile appears favorable, with serious adverse events being relatively rare and consistent with the broader GLP-1 receptor agonist class